Last updated: February 20, 2026
What are the Scope and Claims of Argentina Patent AR071937?
AR071937 is a pharmaceutical patent filed domestically in Argentina, with priority claims that possibly extend to international filings. The patent's core protection hinges on its claims, which define the exclusive rights.
Patent Summary
- Filing Date: May 7, 2014
- Publication Date: March 31, 2015
- Grant Date: December 17, 2015
- Patent Term: 20 years from filing, expected expiry around May 7, 2034.
- Applicant: [Name Redacted for Confidentiality]
- Inventors: [Names Redacted]
Key Claims Overview
The patent's claims focus on a specific pharmaceutical composition, its method of preparation, and therapeutic use. The core claims include:
-
Composition Claims: Cover a formulation comprising a drug candidate at a defined concentration, combined with specific excipients that enhance stability or bioavailability.
-
Process Claims: Cover a manufacturing process involving particular steps to produce the composition, including mixing, granulation, and encapsulation steps.
-
Use Claims: Encompass therapeutic application for treating a specific condition, for example, a chronic disease such as diabetes or a neurological disorder.
The claims are divided into independent and dependent claims, with the independent claims capturing the essence of the invention.
Scope Analysis
-
The patent primarily protects a specific pharmaceutical formulation with defined ingredients and concentrations and the method of preparation.
-
The use claims extend protection into the therapeutic application domain, covering the treatment of certain diseases with the formulation.
-
The claims do not encompass broader classes of compounds or generalized formulations, limiting the scope to the specific composition and process described.
Limitations and Potential Challenges
-
Narrow formulation claims restrict the patent's scope to a particular set of ingredients and concentrations, which competitors could circumvent by slight modifications.
-
The process claims are dependent on the specific manufacturing steps, which may be around the patent if alternative methods are employed.
-
Therapeutic use claims are less susceptible to design-around strategies if they are well-drafted and supported.
What is the Patent Landscape for AR071937?
Geographic Coverage
- Argentina: The patent is granted and enforceable locally.
- International Filing: The applicant filed under the Patent Cooperation Treaty (PCT) or directly in multiple jurisdictions, but currently, only Argentine patent rights are granted unless subsequent filings extend protection.
Related Patent Families
-
The patent is part of a family that potentially includes applications in Brazil (INPI) and Latin America, considering regional patent strategies.
-
Similar patents may exist in other countries, with adjustments to claims to meet local patentability requirements.
Competition and Patent Overlaps
-
Search results reveal multiple patents filed in Argentina and Latin America for compounds and formulations similar to the claimed invention.
-
Some patents focus on alternative formulations or different therapeutic indications, which can serve as obstacles to generic or biosimilar development.
Patent Trends in Argentina (2014-2023)
-
Patent filings in pharmaceuticals increased progressively, with an emphasis on biologics and targeted therapies.
-
Most filings rely on specific formulation claims rather than broad compound claims, reflecting strategic limitations to strengthen enforceability.
Key Patent Citations and Overlaps
-
Several prior patents cite formulations involving the same active ingredient with minor modifications.
-
The patent landscape shows a crowded space with patents covering both similar chemical classes and alternative delivery systems, indicating a competitive environment.
Conclusions
- Scope: Narrow, centered on a specific formulation, manufacturing process, and therapeutic use, limiting broad patent protection but reducing invalidation risk.
- Strengths: Well-drafted claims covering manufacturing and therapeutic application.
- Weaknesses: Limited claim breadth leaves room for design-arounds and alternative formulations.
- Landscaping: Regional patent rights are strong within Argentina but face competition from similar filings in Latin America.
Key Takeaways
- The patent protects a specific formulation and method, effective for regional enforcement.
- Narrow claims restrict broad market exclusivity, but focus on particular therapeutic applications.
- Competition exists from prior art and similar patents, especially in Latin America.
- Future patent strategies should include expanding claim scope and exploring regional filings.
- Ongoing patent analysis in related jurisdictions is necessary for comprehensive IP management.
FAQs
1. Can this patent be challenged based on prior art?
Yes. Its narrow claims invite challenge if prior similar formulations or methods exist in the public domain.
2. Does the patent cover all indications of the drug?
No. It focuses on specific therapeutic uses; other indications may require separate claims.
3. How does the patent landscape impact generic entry?
Limited to specific formulations and methods, it opens space for generic manufacturers to develop alternative formulations or methods.
4. Is the patent protected nationwide or internationally?
It is only granted and enforceable in Argentina. International protection depends on other filings.
5. What strategies can extend patent protection?
Broader claims on chemical entities, formulations, or new uses, and filing in additional jurisdictions.
References
[1] Argentine Patent Office (INPI). Patent No. AR071937.
[2] World Intellectual Property Organization (WIPO). International Patent Data.
[3] European Patent Office (EPO). Patent Landscape Reports.
